A Phase 3, Open-Label, 2-Way Crossover Study to Evaluate the Food Effect on the Pharmacokinetics of Single Oral Dose of TAK-438 with TAK-438 Final Formulation (20 mg) in Healthy Adult Males

Trial Profile

A Phase 3, Open-Label, 2-Way Crossover Study to Evaluate the Food Effect on the Pharmacokinetics of Single Oral Dose of TAK-438 with TAK-438 Final Formulation (20 mg) in Healthy Adult Males

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Vonoprazan (Primary)
  • Indications Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis
  • Focus Pharmacokinetics
  • Sponsors Takeda
  • Most Recent Events

    • 16 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top